Ativan Statistics

Lorazepam looks gentle on the prescription pad, yet benzodiazepines trail only opioids in prescription-overdose deaths. Here's who misuses Ativan, who quietly grows dependent on it, why the mixes turn deadly, and why recovery is the rule.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

The Numbers Behind Ativan Use, Misuse, and Overdose

Ativan is the brand name for lorazepam, one of the most widely prescribed benzodiazepines in the United States. If you’re trying to understand how common Ativan use really is, who takes it, and where the danger sits, the data tells a clear story. The harm isn’t from the pill alone — it’s from long-term use, older-adult prescribing, and the deadly habit of mixing benzodiazepines with opioids and alcohol.

A quick note on what these numbers can and can’t show. Federal surveys and prescription databases usually report benzodiazepines as a class, or lump lorazepam in with “tranquilizers and sedatives,” rather than breaking Ativan out by name. So most figures here describe the family lorazepam belongs to. Where a number names lorazepam or Ativan specifically, it’s flagged.

Coming off Ativan safely is a medically supervised taper, not a cold-turkey leap. Call 988 if you're in danger.
If you’re in danger right now or thinking about suicide, call or text 988 (Suicide & Crisis Lifeline), any time.

What to do:

  • Get into a medically supervised taper to come off Ativan — it’s the safe way, and the meds used in detox make withdrawal far easier than the agony you may be picturing. Find an Ativan detox or taper →
  • If you take an opioid or drink alcohol, get all your prescribing under one doctor — overlapping depressants from different sources is where the danger climbs.
  • If someone mixed Ativan with opioids or alcohol and won’t wake up, call 911. Naloxone reverses opioids but not Ativan — give it anyway if opioids may be involved, then call 911.

Find treatment today →

AddictionHelp.com Fast Facts
  • Benzodiazepine misuse is widespread but a minority pattern: roughly 2% of the U.S. population misused a benzodiazepine in the past year, far more than the under-0.5% who misused z-drug sleep aids[1].
  • Older adults get a heavy share of benzodiazepine prescriptions: about 15% of U.S. emergency-department benzodiazepine discharge prescriptions went to patients 65 and older, despite warnings about falls and confusion in that age group[2].
  • After opioids, benzodiazepines are the medication most often involved in prescription overdoses — and the danger climbs sharply when they’re combined with opioids[3][4].
  • The deadliest pattern is mixing: in a study of 8,665 prescription-depressant overdose deaths, the largest groupings combined benzodiazepines with fentanyl, cocaine, or prescription opioids rather than a benzodiazepine alone[5].

How Common Is Ativan Use and Benzodiazepine Misuse?

What 'misuse' means hereIn survey research, misuse is a behavior category: taking a medication in a way the prescriber didn’t intend, or using it without a prescription at all. It isn’t the same as addiction, and it isn’t a moral label.

Benzodiazepines like lorazepam are among the most commonly used and most commonly misused controlled medications in the country[6]. But “widely prescribed” and “widely misused” are not the same thing, and the gap between them matters.

Roughly 2% of Americans Misuse a Benzodiazepine in a Year

Most people prescribed Ativan take it as directed. In national survey data covering 2015 to 2019, only about 2% of the U.S. population reported misusing a benzodiazepine in the past year, while fewer than 0.5% misused z-drug sleep medications[1]. Misuse means using in a way the prescriber didn’t intend, or without a prescription at all.

That figure reframes the risk. The far more common story isn’t recreational abuse — it’s a person who took lorazepam exactly as prescribed and developed a physical dependence over time.

Benzodiazepine Prescribing Peaked in 2014 and Has Fallen Since

The supply side has shifted. Prescribing of benzodiazepine-type agents (including the sleep drug zolpidem) hit its peak in 2014, then declined year over year to about half that peak by 2023[7]. Federal Medicare and Medicaid figures showed the same downward trend[7].

Less prescribing isn’t a clean win. The same analysis cautions that pulling back on benzodiazepines carries public-health drawbacks as well as benefits — including the risk that people lose access too abruptly or shift to riskier alternatives[7].

Emergency Departments Still Write Millions of Benzodiazepine Prescriptions

Even as overall prescribing fell, the emergency department remained a steady source. Across U.S. emergency departments from 2012 to 2019, there were about 13.8 million visits where a benzodiazepine was prescribed at discharge — roughly 1% of all ED visits in any given year, a rate that held flat over the period[2].

Benzodiazepine Share of ED discharge prescriptions (2012-2019)
Diazepam (Valium) 43.2%[2]
Alprazolam (Xanax) 23.9%[2]
Clonazepam (Klonopin) 15.2%[2]

Lorazepam isn’t the most-prescribed name at ED discharge — diazepam, alprazolam, and clonazepam lead that list[2]. Ativan’s heaviest footprint is inside the hospital, where intravenous lorazepam is a frontline drug for seizures and alcohol withdrawal. For where lorazepam fits among the whole class, the benzodiazepine statistics put the family side by side.

Did you know?

The single most-prescribed benzodiazepine at U.S. emergency-department discharge isn’t Ativan or Xanax — it’s diazepam (Valium), which accounted for 43.2% of all benzodiazepine discharge prescriptions from 2012 to 2019[2]. Lorazepam’s bigger role is the IV form used inside the hospital for seizures and alcohol withdrawal, not the take-home script.

Who Misuses Ativan? Demographics by Age and Sex

Exposure isn't the same as misuseBeing prescribed a medication long-term is exposure, not misuse. Two people can carry very different kinds of risk: one from how often a drug is in their body, the other from how they use it.

The class-level data points to two very different risk pictures: younger people who misuse, and older adults who are prescribed long-term and accumulate quiet harm.

Young Adults Have the Highest Misuse Rates

Across age groups, young adults aged 18 to 25 have the highest rate of tranquilizer and sedative misuse[8]. In national survey data, 42.8% of young adults who used a prescription tranquilizer or sedative in the past year also misused one[8]. Misuse in this group travels with other substance use — opioid misuse in particular — and with mental-health distress including suicidal thinking[8].

Older Adults Carry the Heaviest Prescribing Burden

At the other end of the age range, the concern flips from misuse to exposure. About 15% of emergency-department benzodiazepine discharge prescriptions went to patients 65 and older, despite long-standing warnings about falls, sedation, and confusion in that population[2]. Among older adults who do misuse, the doctor is the most common source — about 38.2% of adults 65 and older got the medication from a physician, a higher share than in younger groups[9].

Older adults also dominate emergency medicine generally. They account for 15% to 25% of U.S. emergency-department visits, about 10% of those visits are medication-related, and they’re admitted to the hospital at 35% to 45% — far above younger patients[10]. A drug like lorazepam, cleared predictably even in aging bodies, lands disproportionately on exactly this high-stakes group.

Long-Term Medical Use Quietly Raises Later Risk

A long-running study followed U.S. adults from age 18 toward 50. By age 35, here’s how prescription-benzodiazepine experience broke down[6]:

Pattern by age 35 Share of adults
Never used or misused benzodiazepines 70.9%[6]
Medical use only 11.3%[6]
Both medical use and misuse 9.8%[6]
Misuse only 14.1%[6]

The striking finding: even adults who only used benzodiazepines as prescribed by age 35 had over twice the odds (adjusted odds ratio 2.17) of later benzodiazepine misuse, and elevated odds of later prescription-opioid misuse, compared with people who never used them[6]. Legitimate medical use isn’t risk-free — it’s a signal that warrants monitoring. The same biology that makes Ativan effective is what makes Ativan addictive, even by the book.

Ativan Addiction Statistics

This is the heart of the matter: how often dependence and addiction actually develop, and what the warning signs look like in the numbers.

Dependence Can Form Even at Prescribed Doses

Tolerance and physical dependence are the expected biology of regular benzodiazepine use, not a sign of moral failure. The long-running study makes the point with hard numbers: medical use alone roughly doubled the odds of later misuse (adjusted odds ratio 2.17), and more frequent medical use by age 35 predicted substance-use-disorder symptoms a decade later[6]. Any history of benzodiazepine misuse by 35 raised the odds of later misuse, opioid misuse, and substance-use-disorder symptoms further still[6].

Misuse Clusters with Other Drug Use

Benzodiazepine misuse rarely travels alone. In young adults, misuse is tightly linked with opioid misuse and with serious mental-health distress[8]. Among older adults who get tranquilizers from a physician, 58.6% also reported past-year opioid misuse — versus 34.9% of those who got the medication free from friends or family — and that physician-source group also carried far higher rates of serious psychological distress (50.1% versus 11.6%)[9]. The pattern is a flashing light: benzodiazepine trouble and opioid trouble tend to arrive together.

The Behavioral Warning Signs the Data Points To

Surveys define “misuse” by behavior, and those behaviors are the same ones that signal a problem with Ativan:

  • Taking more than prescribed or using it to get an effect the prescriber didn’t intend[8]
  • Using it without a prescription, or getting pills from friends, family, or more than one doctor[9]
  • Misuse alongside opioids or other substances, which sharply raises overdose risk[8]
  • Misuse paired with depression, anxiety, or suicidal thinking[8]

If any of this describes you or someone you love, the numbers say you’re not an outlier and you’re not without options. Recognizing it is the turn toward getting free.

Ativan Overdose and ER Statistics

Taken alone, benzodiazepines are relatively forgiving compared with opioids. The data is unambiguous about where the deadly risk concentrates: combinations.

After Opioids, Benzodiazepines Are the Top Prescription Overdose Drug

Across U.S. prescription overdoses, benzodiazepines rank second only to opioids as the medication most commonly involved[3]. In a large Medicare cohort of adults prescribed a benzodiazepine, 0.78% of new users and 0.56% of continuing users had a treated overdose within 30 days of a prescription[3]. Those percentages are small per person, but spread across millions of prescriptions, they add up.

Mixing Ativan with Opioids Multiplies the Danger

The clearest overdose signal in the data is the opioid-plus-benzodiazepine combination. Among adults prescribed both, overdose occurred for 0.4% of patients — about 1 in 231 — on days the two prescriptions overlapped[4].

How the prescriptions were written mattered, too:

Opioid + benzodiazepine overlap Overdose rate
Prescriptions from multiple prescribers 7.0 per 100,000 person-days[4]
Prescriptions from a single prescriber 3.9 per 100,000 person-days[4]

Overlap involving multiple prescribers carried roughly 1.8 times the risk of overlap managed by one[4]. Concurrent use of opioids alongside a benzodiazepine raised short-term overdose risk in every Medicare cohort studied — for older continuing users, opioids carried an adjusted hazard ratio of 1.73, with antipsychotics and antiepileptics adding further risk[3].

Most Benzodiazepine Overdose Deaths Involve a Second Drug

When prescription-depressant overdoses turn fatal, a benzodiazepine is almost never acting alone. In a study of 8,665 prescription-depressant overdose deaths in Massachusetts from 2000 to 2023, the death groupings that involved benzodiazepines also involved other substances[5]:

  • Fentanyl, cocaine, and benzodiazepines together: 34.4% of deaths — the single largest group[5]
  • Prescription opioids and benzodiazepines together: 19.5% of deaths[5]

Over time, fentanyl-driven death groups came to dominate the older prescription-only patterns[5]. The takeaway for anyone using Ativan: the illicit supply is now laced with fentanyl, and a benzodiazepine on top of it is a known killer. This is exactly why mixing Ativan with other depressants is the warning that matters most.

Naloxone Reverses Opioids, Not Ativan

One distinction the overdose data makes life-or-death clear: there is a reversal agent for benzodiazepines (flumazenil) used in some hospital overdose cases, but the take-home opioid antidote is different[11]. Naloxone (Narcan) reverses an opioid overdose but does not reverse benzodiazepines. In a mixed overdose, give naloxone if opioids may be involved — it can reverse the opioid part — but call 911 regardless, because the lorazepam effect and the breathing risk continue after the opioid is reversed.

Benzodiazepines in the Bigger Polysubstance Picture

What 'polysubstance' meansPolysubstance simply means more than one drug is in play at the same time. When an overdose is described this way, no single substance was acting alone — they combined.

Zoom out from the prescription pad to the emergency department and the morgue, and the same theme repeats: lorazepam and its relatives show up as one ingredient in a dangerous mix, far more than as a solo cause of death.

Benzodiazepines Appear in a Distinct Slice of ED Overdoses

A federal analysis of 120,706 emergency-department overdose visits across 18 states in 2017 and 2018 sorted the cases into patterns[12]. Most were opioid-driven, but one clear group stood apart: older women with benzodiazepine involvement made up about 8% of overdose visits[12]. That fingerprint — an older woman, a benzodiazepine, an ED visit — lines up exactly with the long-term-prescribing pattern the numbers keep returning to.

Benzodiazepines Show Up in Roughly 1 in 11 Opioid Overdose Deaths

State mortality data tells the same story. In North Carolina from 2009 to 2018, 53% of opioid overdose deaths involved more than one substance, and the opioid-plus-benzodiazepine combination accounted for 9.0% of all overdose deaths — among the most common deadly pairings[13]. Deaths involving opioids, benzodiazepines, and antiepileptics together were predominantly women (60.6%), echoing the older-woman risk profile seen in the ED data[13]. Nationally, overdose deaths have been climbing across drug categories for two decades, with polydrug toxicity involving synthetic opioids among the sharpest-rising patterns[14].

Benzodiazepines Raise the Stakes Even in Addiction Treatment

The danger of combining benzodiazepines with opioids doesn’t disappear inside treatment. A systematic review of six studies covering 84,452 patients on opioid agonist treatment (methadone or buprenorphine for opioid dependence) found that a benzodiazepine prescription was linked to roughly 1.8 times the risk of all-cause death (hazard ratio 1.83)[15]. It’s a reminder that lorazepam interacts dangerously with opioids whether they’re illicit or prescribed.

What Prescribing and Prevention Data Reveal

The encouraging counterpoint is that the system has started to respond to these numbers, and the responses point straight at the patterns that cause harm.

The FDA Warns Against the Opioid-Benzodiazepine Combination

The combination at the center of nearly every overdose statistic here carries the U.S. Food and Drug Administration’s strongest caution — a black-box warning against concurrent opioid and benzodiazepine use[16]. Researchers reviewing how to safely unwind these prescriptions catalogued 39 original studies and 26 clinical guidelines on deprescribing, evidence that the medical field is actively working to reverse the co-prescribing that drives the deaths[16].

Monitoring Programs Target High-Risk Prescribing

States have rolled out prescription drug monitoring programs — databases that flag controlled-substance prescriptions — to curb unsafe benzodiazepine dispensing and the overdoses tied to it, with particular attention to adolescents and young adults[17]. The broader literature frames benzodiazepines as a class of genuine therapeutic value whose rising rates of misuse, dependence, and overdose — especially alongside opioids — are the real public-health concern[18].

What the Numbers Say About Getting off Ativan

The data also carries a hopeful thread: the risk is concentrated in specific, fixable patterns, and the way out is well established.

Shorter, Looser Use Patterns Show the Risk Isn’t Only About High Doses

A counterintuitive finding from the Medicare cohort: overdose risk was actually higher with fewer days’ supply and among continuing users with lower baseline benzodiazepine exposure[3]. In plain terms, the danger isn’t limited to heavy, high-dose users — irregular and lower-exposure use carries real risk too, often because that’s where mixing and instability show up. No level of casual benzodiazepine use is automatically “safe.”

The Real Lever Is Stopping the Combinations and Tapering Safely

Every overdose signal in the data points the same direction: opioids plus benzodiazepines, multiple prescribers, and an unstable illicit supply[4][3][5]. Each of those is addressable. Coordinating care under one prescriber, removing the opioid-benzodiazepine overlap, and coming off lorazepam through a slow, medically supervised taper is how people move from the high-risk side of these statistics to the safe side. To see what that looks like step by step, read about Ativan detox and the Ativan withdrawal timeline.

Getting Help for Ativan Addiction

Behind every one of these numbers is a person, and the most important statistic isn’t in any table: the great majority of people who taper with support get off Ativan and stay off. Dependence on lorazepam is a recognized, treatable medical condition, and recovery is the expected outcome, not a long shot.

If these patterns describe your life — long-term daily use, mixing with opioids or alcohol, getting pills from more than one source, or a dependence that crept in even though you followed the prescription — the path forward is the same. Don’t stop on your own. Get into a medically supervised detox or taper, and lean on the counseling that makes it last. The way out is private, it starts with a single conversation, and the withdrawal you may be dreading is far gentler with help than it is alone.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

How common is benzodiazepine misuse in the United States?

Most people who take a benzodiazepine like Ativan use it as prescribed. In national survey data covering 2015 to 2019, only about 2% of the U.S. population reported misusing a benzodiazepine in the past year, and fewer than 0.5% misused z-drug sleep medications[1]. Misuse means using in a way the prescriber did not intend or without a prescription. Keep in mind that federal data usually reports benzodiazepines as a class rather than breaking out lorazepam by name, so these figures describe the family Ativan belongs to.

Who is most likely to misuse Ativan and other benzodiazepines?

Two very different groups stand out. Young adults aged 18 to 25 have the highest rate of tranquilizer and sedative misuse, and among past-year users in that age group, 42.8% also misused one, often alongside opioids and mental-health distress[8]. At the other end, older adults carry the heaviest prescribing burden: about 15% of emergency-department benzodiazepine discharge prescriptions went to patients 65 and older, and when older adults do misuse, the doctor is the most common source, at about 38.2%[2][9].

Is it dangerous to take Ativan with opioids or alcohol?

Yes, and the data is blunt about it. After opioids, benzodiazepines are the medication most commonly involved in prescription overdoses[3]. Among adults prescribed both an opioid and a benzodiazepine, overdose occurred for about 1 in 231 patients on days the prescriptions overlapped, and the risk was roughly 1.8 times higher when multiple prescribers were involved[4]. Each of these drugs slows breathing, so stacking them is how an ordinary night can turn into an overdose. If someone is unresponsive or breathing slowly, call 911.

How often do benzodiazepine overdoses turn fatal, and what is usually involved?

When prescription-depressant overdoses turn fatal, a benzodiazepine is almost never acting alone. In a study of 8,665 prescription-depressant overdose deaths in Massachusetts from 2000 to 2023, the largest death grouping combined fentanyl, cocaine, and benzodiazepines (34.4%), and another major group combined prescription opioids and benzodiazepines (19.5%)[5]. Over time, fentanyl-driven patterns came to dominate. The lesson for anyone using Ativan is that the illicit supply is now laced with fentanyl, and adding a benzodiazepine is a known killer.

Does naloxone (Narcan) reverse an Ativan overdose?

No. There is a benzodiazepine reversal agent called flumazenil that is used in some hospital overdose cases, but the take-home opioid antidote is different[11]. Naloxone reverses an opioid overdose but does not reverse benzodiazepines. Because most fatal overdoses involve mixing, you should still give naloxone if opioids may be involved, since it can reverse the opioid part, but call 911 regardless because the lorazepam effect and the breathing risk continue after the opioid is reversed.

Can people really recover from Ativan dependence?

Yes, and recovery is the expected outcome with proper care. The risk in the data is concentrated in fixable patterns: mixing benzodiazepines with opioids, prescriptions from multiple prescribers, and an unstable illicit supply[4][3][5]. Each of those is addressable. Coordinating care under one prescriber, removing the opioid overlap, and coming off lorazepam through a slow, medically supervised taper moves people from the high-risk side of these statistics to the safe side. You can find treatment and people who can help at /find-treatment-help/.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

18 Sources
  1. McHugh RK, Votaw VR, Trapani EW, McCarthy MD (2023). Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2023.1129447
  2. Ramdin C, Mina G, Nelson L, Mazer-Amirshahi M (2024). Benzodiazepine Discharge Prescriptions From Emergency Departments Across the United States Between 2012 and 2019: A National Analysis. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001310
  3. Maust DT, Bohnert ASB, Strominger J, Goldstick JE (2023). Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-023-00674-x
  4. Chua K, Brummett CM, Ng S, Bohnert ASB (2021). Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. JAMA network open. https://doi.org/10.1001/jamanetworkopen.2021.20353
  5. Lee H, Dong H, Jalali MS, Stringfellow EJ (2026). Prescription Depressant-Involved Overdose Mortality in Massachusetts (2000-2023): A Cohort Study. Journal of general internal medicine. https://doi.org/10.1007/s11606-025-10113-8
  6. McCabe SE, Schulenberg JE, Wilens TE, Schepis TS, McCabe VV, Veliz P (2023). Transitions in Prescription Benzodiazepine Use and Misuse and in Substance Use Disorder Symptoms Through Age 50. Psychiatric services (Washington, D.C.). https://doi.org/10.1176/appi.ps.20220247
  7. Yang Z, Shader RI, Greenblatt DJ (2026). Time Trends in Prescribing of Anxiolytic, Sedative, and Hypnotic Drugs in the United States. Clinical therapeutics. https://doi.org/10.1016/j.clinthera.2025.12.014
  8. Schepis TS, Teter CJ, Simoni-Wastila L, McCabe SE (2018). Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2018.06.013
  9. Schepis TS, McCabe SE (2019). Prescription Tranquilizer/Sedative Sources for Misuse in Older Adults. Substance use & misuse. https://doi.org/10.1080/10826084.2019.1613434
  10. Metts E, Carroll S, Posen A, Rech MA, Weant K (2026). Medication Safety Strategies for Geriatric Patients in the Emergency Department: A Narrative Review. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. https://doi.org/10.1111/acem.70325
  11. Weaver MF (2015). Prescription Sedative Misuse and Abuse. The Yale journal of biology and medicine.
  12. Liu S, Vivolo-Kantor A (2020). A latent class analysis of drug and substance use patterns among patients treated in emergency departments for suspected drug overdose. Addictive behaviors. https://doi.org/10.1016/j.addbeh.2019.106142
  13. Figgatt MC, Austin AE, Cox ME, Proescholdbell S, Marshall SW, Naumann RB (2021). Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018. Drug and alcohol dependence. https://doi.org/10.1016/j.drugalcdep.2020.108504
  14. Nguyen A, Wang J, Holland KM, Ehlman DC, Welder LE, Miller KD, et al. (2024). Trends in Drug Overdose Deaths by Intent and Drug Categories, United States, 1999‒2022. American journal of public health. https://doi.org/10.2105/ajph.2024.307745
  15. Hestevik CH, Evensen LH, Kornør H, Skeie I (2024). The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review. BMC psychiatry. https://doi.org/10.1186/s12888-024-06191-3
  16. Wang Y, Wilson DL, Fernandes D, Adkins LE, Bantad A, Copacia C, et al. (2023). Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review. Journal of clinical medicine. https://doi.org/10.3390/jcm12051788
  17. Toce MS, Michelson KA, Hudgins JD, Olson KL, Monuteaux MC, Bourgeois FT (2023). Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults. Clinical toxicology (Philadelphia, Pa.). https://doi.org/10.1080/15563650.2023.2181092
  18. Figg JW, Love CA, Sorathia V, Engelbart M, Turner A, Elton A (2026). Benzodiazepines at the crossroads: navigating therapeutic promise and perils of misuse. Annals of general psychiatry. https://doi.org/10.1186/s12991-025-00627-0
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.